Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: <scp>PRONTO‐Pump</scp> ‐2

Mark Warren, Bruce W. Bode, Jang Ik Cho, Rong Liu, Janet Tobian, Thomas A. Hardy, Farai Chigutsa, Moshe Phillip, Barry Horowitz, Debra A. Ignaut

Diabetes Obesity and Metabolism · 2021 · 37 citations · 14 references

DOIFull text

Open access

Abstract

URLi was efficacious, providing superior PPG control and less time in hypoglycaemia but with more frequent infusion-site reactions compared with lispro when administered by CSII.

References

14